252 related articles for article (PubMed ID: 33477492)
21. Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro.
Lanave G; Cavalli A; Martella V; Fontana T; Losappio R; Tempesta M; Decaro N; Buonavoglia D; Camero M
J Virol Methods; 2017 Oct; 248():207-211. PubMed ID: 28760649
[TBL] [Abstract][Full Text] [Related]
22. Isolation and molecular characterizations of canine distemper virus from a naturally infected Korean dog using Vero cells expressing dog signaling lymphocyte activation molecule.
Yang DK; Kim HH; Lee S; Yoon YS; Park J; Oh D; Yoo JY; Ji M; Han B; Oh S; Hyun BH
J Vet Sci; 2020 Sep; 21(5):e64. PubMed ID: 33016015
[TBL] [Abstract][Full Text] [Related]
23. [Establishment and application of a Vero cell line stably expressing raccoon dog SLAM, the cellular receptor of canine distemper virus].
Zhao J; Yan R; Zhang H; Zhang L; Hu B; Bai X; Shao X; Chai X; Yan X; Wu W
Wei Sheng Wu Xue Bao; 2012 Dec; 52(12):1515-23. PubMed ID: 23457801
[TBL] [Abstract][Full Text] [Related]
24. Canine distemper virus infects canine keratinocytes and immune cells by using overlapping and distinct regions located on one side of the attachment protein.
Langedijk JP; Janda J; Origgi FC; Örvell C; Vandevelde M; Zurbriggen A; Plattet P
J Virol; 2011 Nov; 85(21):11242-54. PubMed ID: 21849439
[TBL] [Abstract][Full Text] [Related]
25. Selective SLAM/CD150 receptor-detargeting of canine distemper virus.
Gradauskaite V; Khosravi M; Plattet P
Virus Res; 2022 Sep; 318():198841. PubMed ID: 35649483
[TBL] [Abstract][Full Text] [Related]
26. Antiviral efficacy of favipiravir against canine distemper virus infection in vitro.
Xue X; Zhu Y; Yan L; Wong G; Sun P; Zheng X; Xia X
BMC Vet Res; 2019 Sep; 15(1):316. PubMed ID: 31477101
[TBL] [Abstract][Full Text] [Related]
27. Canine distemper virus envelope protein interactions modulated by hydrophobic residues in the fusion protein globular head.
Avila M; Khosravi M; Alves L; Ader-Ebert N; Bringolf F; Zurbriggen A; Plemper RK; Plattet P
J Virol; 2015 Jan; 89(2):1445-51. PubMed ID: 25355896
[TBL] [Abstract][Full Text] [Related]
28. Infectious Progression of Canine Distemper Virus from Circulating Cerebrospinal Fluid into the Central Nervous System.
Takenaka A; Sato H; Ikeda F; Yoneda M; Kai C
J Virol; 2016 Oct; 90(20):9285-92. PubMed ID: 27489268
[TBL] [Abstract][Full Text] [Related]
29. Canine distemper virus utilizes different receptors to infect chicken embryo fibroblasts and vero cells.
Chen J; Liang X; Chen PF
Virol Sin; 2011 Apr; 26(2):139-45. PubMed ID: 21468937
[TBL] [Abstract][Full Text] [Related]
30. Identification of key residues in virulent canine distemper virus hemagglutinin that control CD150/SLAM-binding activity.
Zipperle L; Langedijk JP; Orvell C; Vandevelde M; Zurbriggen A; Plattet P
J Virol; 2010 Sep; 84(18):9618-24. PubMed ID: 20631152
[TBL] [Abstract][Full Text] [Related]
31. Effective primary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes.
Lednicky JA; Meehan TP; Kinsel MJ; Dubach J; Hungerford LL; Sarich NA; Witecki KE; Braid MD; Pedrak C; Houde CM
J Virol Methods; 2004 Jun; 118(2):147-57. PubMed ID: 15081610
[TBL] [Abstract][Full Text] [Related]
32. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus.
Carvalho OV; Saraiva GL; Ferreira CG; Felix DM; Fietto JL; Bressan GC; Almeida MR; Silva Júnior A
Can J Vet Res; 2014 Oct; 78(4):283-9. PubMed ID: 25355997
[TBL] [Abstract][Full Text] [Related]
33. Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression.
Sawatsky B; Wong XX; Hinkelmann S; Cattaneo R; von Messling V
J Virol; 2012 Apr; 86(7):3658-66. PubMed ID: 22278252
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of reduction of virus release and cell-cell fusion in persistent canine distemper virus infection.
Meertens N; Stoffel MH; Cherpillod P; Wittek R; Vandevelde M; Zurbriggen A
Acta Neuropathol; 2003 Oct; 106(4):303-10. PubMed ID: 12827396
[TBL] [Abstract][Full Text] [Related]
35. In vitro efficacy of ribavirin against canine distemper virus.
Elia G; Belloli C; Cirone F; Lucente MS; Caruso M; Martella V; Decaro N; Buonavoglia C; Ormas P
Antiviral Res; 2008 Feb; 77(2):108-13. PubMed ID: 17949825
[TBL] [Abstract][Full Text] [Related]
36. Tropism and molecular pathogenesis of canine distemper virus.
Rendon-Marin S; da Fontoura Budaszewski R; Canal CW; Ruiz-Saenz J
Virol J; 2019 Mar; 16(1):30. PubMed ID: 30845967
[TBL] [Abstract][Full Text] [Related]
37. Use of SLAM and PVRL4 and identification of pro-HB-EGF as cell entry receptors for wild type phocine distemper virus.
Melia MM; Earle JP; Abdullah H; Reaney K; Tangy F; Cosby SL
PLoS One; 2014; 9(8):e106281. PubMed ID: 25171206
[TBL] [Abstract][Full Text] [Related]
38. Structure and supramolecular organization of the canine distemper virus attachment glycoprotein.
Kalbermatter D; Jeckelmann JM; Wyss M; Shrestha N; Pliatsika D; Riedl R; Lemmin T; Plattet P; Fotiadis D
Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2208866120. PubMed ID: 36716368
[TBL] [Abstract][Full Text] [Related]
39. Replication competence of canine distemper virus in cell lines expressing signaling lymphocyte activation molecule (SLAM) of goat, sheep and dog origin.
Yadav AK; Rajak KK; Kumar A; Bhatt M; Chakravarti S; Muthu S; Dubal ZB; Khulape S; Yousuf RW; Rai V; Kumar B; Muthuchelvan D; Gupta PK; Singh RP; Singh R
Microb Pathog; 2021 Jul; 156():104940. PubMed ID: 33962006
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion.
Schmid E; Zurbriggen A; Gassen U; Rima B; ter Meulen V; Schneider-Schaulies J
J Virol; 2000 Aug; 74(16):7554-61. PubMed ID: 10906209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
